A Question of Timing: 10-year Retrospective Analysis on the Use of Antenatal Steroids for Imminent Preterm Birth

Abstract

Objective Antenatal steroids improve the neonatal outcome if they are administered within a therapeutic window of seven days before preterm birth. The aim of this study was to evaluate the timing of antenatal steroids for imminent preterm birth at a single center in Germany.

Material and Methods A 10-year retrospective analysis of 843 preterm births between 24/0 and 33/6 weeks was performed from January 2008 to December 2017 at a German university hospital. We evaluated the timing of antenatal steroids according to the indication for their application. Descriptive statistics and binomial regression were performed to analyze factors influencing the timing of antenatal steroid administration.

Results Of 843 preterm births below 34 weeks included in our study, 752 pregnant women received antenatal steroids (89.2%). Only 301/843 women (35.7%) gave birth within the optimal window of 7 days after antenatal steroids. 91/843 women (10.8%) did not receive steroids. 130/843 women (15.4%) only received one dose, 76/843 (9.0%) gave birth within 8 to 14 days, and 245/843 (29.1%) more than 14 days later. In a binomial regression model, preterm premature rupture of membranes (OR 3.40, 95% CI 1.81 to 6.39, p<0.001), fetal growth restriction (OR 3.27, 95% CI 1.63 to 6.58, p=0.001), and preeclampsia (OR 2.83, 95% CI 1.37 to 5.83, p=0.005) were positively associated with optimal timing.

Conclusion Two thirds of women with preterm birth before 34 weeks received antenatal steroids outside the optimal therapeutic window. Further research is needed to achieve an optimal effect of antenatal steroids on neonatal outcome and to reduce untimely as well as unnecessary interventions.

Key words

preterm birth - betamethasone - antenatal care - prediction - antenatal steroids

• References

• 1 Blencowe H, Cousens S, Oestergaard MZ. et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379: 2162-2172
• 2 Berger R, Abele H, Bahlmann F. et al. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) – Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birt. Z Geburtshilfe Neonatol 2019; 223: 304-316
• 3 Di Renzo GC, Cabero Roura L, Facchinetti F. et al. Preterm labor and birth management: recommendations from the European Association of Perinatal Medicine. J Matern Neonatal Med 2017; 30: 2011-2030
• 4 American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol 2017; 130: e102-e109
• 5 NICE. Preterm labour and birth overview. Natl Inst Heal Care Excell 2019; 1-12
• 6 Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515-525
• 7 Carlo WA, McDonald SA, Fanaroff AA. et al. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks’ gestation. JAMA - JAMA 2011; 306: 2348-2358
• 8 Mori R, Kusuda S, Fujimura M. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. J Pediatr 2011; 159: 110-114.e1
• 9 Roberts D, Brown J, Medley N. et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017; 3: CD004454
• 10 Norman M, Piedvache A, Børch K. et al. Association of short antenatal corticosteroid administration-to-birth intervals with survival and morbidity among very preterm infants results from the EPICE cohort. JAMA Pediatr 2017; 171: 678-686
• 11 Ring AM, Garland JS, Stafeil BR. et al. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study. Am J Obstet Gynecol 2007; 196: 457.e1-6
• 12 Wilms FF, Vis JY, Pattinaja DAPM. et al. Relationship between the time interval from antenatal corticosteroid administration until preterm birth and the occurrence of respiratory morbidity. Am J Obstet Gynecol 2011; 205: 49.e1-7
• 13 Razaz N, Skoll A, Fahey J. et al. Trends in optimal, suboptimal, and questionably appropriate receipt of antenatal corticosteroid prophylaxis. Obstet Gynecol 2015; 125: 288-296
• 14 Levin HI, Ananth CV, Benjamin-Boamah C. et al. Clinical indication and timing of antenatal corticosteroid administration at a single centre. BJOG 2016; 123: 409-414
• 15 Fuchs IB, Henrich W, Osthues K. et al. Sonographic cervical length in singleton pregnancies with intact membranes presenting with threatened preterm labor. Ultrasound Obstet Gynecol 2004; 24: 554-557
• 16 Gyamfi-Bannerman C, Thom EA, Blackwell SC. et al. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 2016; 374: 1311-1320
• 17 Liebowitz M, Clyman RI. Antenatal betamethasone: a prolonged time interval from administration to delivery is associated with an increased incidence of severe intraventricular hemorrhage in infants born before 28 weeks gestation. J Pediatr 2016; 177: 114-120.e1
• 18 Norberg H, Kowalski J, Maršál K. et al. Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study. BJOG 2017; 124: 1567-1574
• 19 Frändberg J, Sandblom J, Bruschettini M. et al. Antenatal corticosteroids: a retrospective cohort study on timing, indications and neonatal outcome. Acta Obstet Gynecol Scand 2018; 97: 591-597
• 20 Boesveld M, Heida KY, Oudijk MA. et al. Evaluation of antenatal corticosteroid prescribing patterns among 984 women at risk for preterm delivery. J Matern Neonatal Med 2014; 27: 516-519
• 21 Adams TM, Kinzler WL, Chavez MR. et al. The timing of administration of antenatal corticosteroids in women with indicated preterm birth. Am J Obstet Gynecol 2015; 212: 645.e1-4
• 22 Villar J, Papageorghiou AT, Knight HE. et al. The preterm birth syndrome: a prototype phenotypic classification. Am J Obstet Gynecol 2012; 206: 119-123
• 23 Grobman WA, Lai Y, Iams JD. et al. Prediction of spontaneous preterm birth among nulliparous women with a short cervix. J Ultrasound Med 2016; 35: 1293-1297
• 24 Gomez R, Romero R, Medina L. et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol 2005; 192: 350-359
• 25 Owen J, Szychowski JM, Hankins G. et al. Does midtrimester cervical length ≥25 mm predict preterm birth in high-risk women?. Am J Obstet Gynecol 2010; 203: 393.e1-393.e5
• 26 Makhija NK, Tronnes AA, Dunlap BS. et al. Antenatal corticosteroid timing: accuracy after the introduction of a rescue course protocol. Am J Obstet Gynecol 2016; 214: 120.e1-6